A Study of LY2216684 and Digoxin in Healthy Subjects

NCT01266590 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

30

Enrollment

INDUSTRY

Sponsor class

Conditions

Major Depressive Disorder

Interventions

DRUG: LY2216684
DRUG: Digoxin

Sponsor

Eli Lilly and Company